BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37432888)

  • 21. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism.
    Kaneko H; Umakoshi H; Ishihara Y; Nanba K; Tsuiki M; Kusakabe T; Satoh-Asahara N; Yasoda A; Tagami T
    J Endocr Soc; 2020 Sep; 4(9):bvaa100. PubMed ID: 32803096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
    Umakoshi H; Sakamoto R; Matsuda Y; Yokomoto-Umakoshi M; Nagata H; Fukumoto T; Ogata M; Ogawa Y
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
    Kobayashi H; Nakamura Y; Abe M; Tanabe A; Sone M; Katabami T; Kurihara I; Ichijo T; Tsuiki M; Izawa S; Wada N; Yoneda T; Takahashi K; Tamura K; Ogawa Y; Inagaki N; Yamamoto K; Rakugi H; Naruse M;
    Endocr J; 2023 May; 70(5):489-500. PubMed ID: 36792218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism.
    Wada N; Miyoshi A; Usubuchi H; Terae S; Shibayama Y; Takahashi B; Baba S; Sugawara H; Obara S
    Endocr J; 2021 Jan; 68(1):45-51. PubMed ID: 32848105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.
    Kaneko H; Umakoshi H; Ishihara Y; Sugawa T; Nanba K; Tsuiki M; Kusakabe T; Satoh-Asahara N; Yasoda A; Tagami T
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):737-742. PubMed ID: 31618467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
    Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
    BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
    Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
    J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
    Schirpenbach C; Seiler L; Maser-Gluth C; Rüdiger F; Nickel C; Beuschlein F; Reincke M
    Eur J Endocrinol; 2006 Jun; 154(6):865-73. PubMed ID: 16728547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.
    Liu B; Hu J; Song Y; He W; Cheng Q; Wang Z; Feng Z; Du Z; Xu Z; Yang J; Li Q; Yang S;
    Endocr Pract; 2021 Apr; 27(4):326-333. PubMed ID: 33779561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
    Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
    J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of the post-captopril test in primary aldosteronism.
    Castro OL; Yu X; Kem DC
    Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism.
    Umakoshi H; Xiaomei Y; Ichijo T; Kamemura K; Matsuda Y; Fujii Y; Kai T; Fukuoka T; Sakamoto R; Ogo A; Suzuki T; Ogasawara T; Tsuiki M; Naruse M;
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):170-176. PubMed ID: 27474252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Accuracy of the Aldosterone-to-Active Renin Ratio for Detecting Primary Aldosteronism.
    Pilz S; Keppel MH; Trummer C; Theiler-Schwetz V; Pandis M; Borzan V; Pittrof M; Obermayer-Pietsch B; Grübler MR; Verheyen N; Stepan V; Meinitzer A; Voelkl J; März W; Tomaschitz A
    J Endocr Soc; 2019 Sep; 3(9):1748-1758. PubMed ID: 31528833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
    Murata M; Kitamura T; Tamada D; Mukai K; Kurebayashi S; Yamamoto T; Hashimoto K; Hayashi RD; Kouhara H; Takeiri S; Kajimoto Y; Nakao M; Hamasaki T; Otsuki M; Shimomura I
    J Hypertens; 2017 May; 35(5):1079-1085. PubMed ID: 28129245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
    Mulatero P; Milan A; Fallo F; Regolisti G; Pizzolo F; Fardella C; Mosso L; Marafetti L; Veglio F; Maccario M
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2618-23. PubMed ID: 16670162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension.
    Alam S; Kandasamy D; Goyal A; Vishnubhatla S; Singh S; Karthikeyan G; Khadgawat R
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):895-903. PubMed ID: 33393127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS.
    Thuzar M; Young K; Ahmed AH; Ward G; Wolley M; Guo Z; Gordon RD; McWhinney BC; Ungerer JP; Stowasser M
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31676899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of Different Doses of ACTH Used in ACTH Stimulation Test to Determine the Subtypes of Primary Aldosteronism].
    Qiu P; Zang L; Zhang L; Lyu Z; Mu Y; Guo Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):210-216. PubMed ID: 38322542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
    Hu Y; Zhang J; Liu W; Su X
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.